TMCnet News
Ohio's Yes on Issue 2: U.S. Consumers Pay $84,000 for a Drug Egyptians Buy for $83!!Sovaldi, the hepatitis C wonder drug, sells for $84,000 in the U.S. but for only $83 in Egypt, says the British tabloid the Daily Mail. The newspaper also reports Egyptian entrepreneurs are providing round-trip air fare to Egypt, a five day tour of the countryside and a Sovaldi cure for $7,000 to foreigners. In 2014, Gilead Sciences agreed to make Sovaldi available for about $900 per treatment to Egypt. Whether it's $83 or $900, U.S. consumers and taxpayers are heavily subsidizing the treatment of hundreds of thousands of hepatitis C sufferers in Egypt while in the U.S. Sovaldi's price tag (News - Alert) has forced Medicaid and private insurers to ration the drug, making it available only to persons in the final stages of the potentially deadly liver disease. Source (News - Alert): Daily Mail and Reuters. Background on Ohio Ballot Issue 2 The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson. You can learn more by visiting yesonissue2.com or following us on Facebook and Twitter. Paid (News - Alert) for by Ohio Taxpayers for Lower Drug Prices View source version on businesswire.com: http://www.businesswire.com/news/home/20170919006722/en/ |
